Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Canntab Therapeutics Ltd (PILL.CN)

Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Canntab Therapeutics Ltd 1 Adelaide Street East Suite 801 Toronto ON M5C 2V9 CAN

https://www.canntab.ca P: 833-301-3812

Description:

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.

Key Statistics

Overview:

Market Capitalization, $K 195
Shares Outstanding, K 38,909
Annual Sales, $ 293 K
Annual Net Income, $ -3,689 K
Last Quarter Sales, $ -22 K
Last Quarter Net Income, $ -413 K
60-Month Beta 0.17
% of Institutional Shareholders 30.21%

Growth:

1-Year Return -95.65%
3-Year Return -99.31%
5-Year Return -99.71%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.09
Annual Dividend Rate, $ 0.00
Most Recent Dividend 2.900 on 03/08/16
Next Ex-Dividends Date 03/08/16
Dividend Payable Date 04/30/16
Dividend Payout Ratio 0.00%
Most Recent Split 1-200 on 04/20/18

PILL.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -107.50%
Profit Margin % -1,257.55%
Debt/Equity N/A
Price/Sales 2.65
Price/Book N/A
Book Value/Share -0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar